Antonucci L, Fagman JB, Kim JY, Todoric J, Gukovsky I, Mackey M, Ellisman MH & Karin M 2015 Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress. PNAS 112 E6166–E6174. (https://doi.org/10.1073/pnas.1519384112)
Avniel-Polak S, Leibowitz G, Riahi Y, Glaser B, Gross DJ & Grozinsky- Glasberg S 2016 Abrogation of autophagy by chloroquine alone or in combination with mTOR Inhibitors Induces apoptosis in neuroendocrine tumor cells. Neuroendocrinology 103 724–737. (https://doi.org/10.1159/000442589)
Avniel-Polak S, Leibowitz G, Doviner V, Gross DJ & Grozinsky-Glasberg S 2018 Combining chloroquine with RAD001 inhibits tumor growth in a NEN mouse model. Endocrine-Related Cancer 25 677–686. (https://doi.org/10.1530/ERC-18-0121)
Bertolino P, Tong WM, Galendo D, Wang ZQ & Zhang CX 2003 Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Molecular Endocrinology 17 1880–1892. (https://doi.org/10.1210/me.2003-0154)
Chude CI & Amaravadi RK 2017 Targeting autophagy in cancer: update on clinical trials and novel inhibitors. International Journal of Molecular Sciences 18 1279. (https://doi.org/10.3390/ijms18061279)
Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, et al. 2001 A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. PNAS 98 1118–1123. (https:// doi.org/10.1073/pnas.98.3.1118)
Dasari A, Shen C, Halperin D, Zhao B, Zhou S, Xu Y, Shih T & Yao JC 2017 Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncology 3 1335–1342. (https://doi.org/10.1001/jamaoncol.2017.0589)
Furuyama K, Kawaguchi Y, Akiyama H, Horiguchi M, Kodama S, Kuhara T, Hosokawa S, Elbahrawy A, Soeda T, Koizumi M, et al. 2011 Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nature Genetics 43 34–41. (https://doi.org/10.1038/ng.722)
Gomez-Guzman M, Jimenez R, Romero M, Sanchez M, Zarzuelo MJ, Gomez-Morales M, O’Valle F, Lopez-Farre AJ, Algieri F, Galvez J, et al. 2014 Chronic hydroxychloroquine improves endothelial dysfunction and protects kidney in a mouse model of systemic lupus erythematosus. Hypertension 64 330–337. (https://doi.org/10.1161/ HYPERTENSIONAHA.114.03587)
Iguchi H, Hayashi I & Kono A 1990 A somatostatin-secreting cell line established from a human pancreatic islet cell carcinoma (somatostatinoma): release experiment and immunohistochemical study. Cancer Research 50 3691–3693.
Kaku M, Nishiyama T, Yagawa K & Abe M 1980 Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma. Gan 71 596–601.
Klionsky DJ & Emr SD 2000 Autophagy as a regulated pathway of cellular degradation. Science 290 1717–1721. (https://doi. org/10.1126/science.290.5497.1717)
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al. 2016 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12 1–222. (https://doi.org/10.108 0/15548627.2015.1100356)
Lee L, Igarashi H, Fujimori N, Hijioka M, Kawabe K, Oda Y, Jensen RT & Ito T 2015 Long-term outcomes and prognostic factors in 78 Japanese patients with advanced pancreatic neuroendocrine neoplasms: a single-center retrospective study. Japanese Journal of Clinical Oncology 45 1131–1138. (https://doi.org/10.1093/jjco/ hyv143)
Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK & Kay GF 2007 Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. International Journal of Cancer 120 259–267. (https://doi.org/10.1002/ ijc.22288)
Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y, Oka Y & Yamamura K 1990 Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms. Endocrinology 127 126–132. (https://doi.org/10.1210/endo-127-1-126)
Ogata M, Hino S, Saito A, Morikawa K, Kondo S, Kanemoto S, Murakami T, Taniguchi M, Tanii I, yoshinaga K, et al. 2006 Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 26 9220–9231. (https://doi.org/10.1128/MCB.01453-06)
Rempenault C, Combe B, Barnetche T, Gaujoux-Viala C, Lukas C, Morel J & Hua C 2018 Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis. Annals of the Rheumatic Diseases 77 98–103. (https://doi.org/10.1136/annrheumdis-2017-211836)
Ron D & Walter P 2007 Signal integration in the endoplasmic reticulum unfolded protein response. Nature Reviews: Molecular Cell Biology 8 519–529. (https://doi.org/10.1038/nrm2199)
Tabas I & Ron D 2011 Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nature Cell Biology 13 184–190. (https://doi.org/10.1038/ncb0311-184)
Wiedmer T, Blank A, Pantasis S, Normand L, Bill R, Krebs P, Tschan MP, Marinoni I & Perren A 2017 Autophagy inhibition improves sunitinib efficacy in pancreatic neuroendocrine tumors via a lysosome-dependent mechanism. Molecular Cancer Therapeutics 16 2502–2515. (https://doi.org/10.1158/1535-7163.MCT-17-0136)
Xu R, Ji Z, Xu C & Zhu J 2018 The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers: asystematic review and meta-analysis. Medicine 97 e12912. (https://doi.org/10.1097/MD.0000000000012912)
Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, Abdalla EK, Fleming JB, Vauthey JN, Rashid A, et al. 2008 One hundred years after ‘carcinoid’: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. Journal of Clinical Oncology 26 3063–3072. (https://doi.org/10.1200/ JCO.2007.15.4377)
Yoshida H, Okada T, Haze K, Yanagi H, Yura T, Negishi M & Mori K 2000 ATF6 activated by proteolysis binds in the presence of NF-Y (CBF) directly to the cis-acting element responsible for the mammalian unfolded protein response. Molecular and Cellular Biology 20 6755–6767. (https://doi.org/10.1128/mcb.20.18.6755-6767.2000)